Grifols Expansion Plans Include Biotech Equity, New US Manufacturing Facilities
Executive Summary
Taking a 20% equity stake in US biotech Singulex and planning to build new manufacturing facilities in the US and Europe reflect the global expansion plans of Spain’s plasma product manufacturer Grifols, the third-largest in the world.